Tettey, Prudence <br/><br/>
An adverse lipid profile and increased levels of adiposity significantly predict clinical course after a first demyelinating event.  [electronic resource] 

 -  Journal of neurology, neurosurgery, and psychiatry  05 2017 
 - 395-401 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1468-330X 
<br/><br/><label>Standard No.: </label>10.1136/jnnp-2016-315037  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adiposity<br/>Adult<br/>Cholesterol--blood<br/>Cholesterol, HDL--blood<br/>Demyelinating Diseases<br/>Disease Progression<br/>Female<br/>Humans<br/>Lipids--blood<br/>Male<br/>Multiple Sclerosis--blood<br/>Prospective Studies<br/>Risk Factors<br/>Time Factors<br/>Triglycerides--blood